Effect of losartan on renal microvasculature during chronic inhibition of nitric oxide visualized by micro-CT
Authors:
- Loudes A. FortepianiLFLoudes A. Fortepiani
- M. Clara Ortiz RuizMRM. Clara Ortiz Ruiz
- Federico PassardiFPFederico Passardi
- Michael D. BentleyMBMichael D. Bentley
- Joaquín García-EstañJoaquín García-Estañ
- Erik L. RitmanERErik L. Ritman
- J. Carlos RomeroJRJ. Carlos Romero
- 1 November 2003
- journal article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 285 (5) , F852-F860
Abstract
Chronic inhibition of nitric oxide (NO) synthase with the competitive l-arginine analog NG-nitro-l-arginine methyl ester (l-NAME) leads to an elevated systemic blood pressure and reduction in renal blood flow without significant changes in urinary sodium and water excretion. Simultaneous administration of ANG II AT1 receptor antagonist losartan and l-NAME prevents the alterations in blood pressure and renal hemodynamics. Microcomputed tomography (micro-CT) was used to investigate the role of ANG II in the changes of renal microvasculature during chronic NO inhibition. Sprague-Dawley rats were given l-NAME with or without AT1 receptor antagonist losartan (40 mg · kg-1 · day-1 each) in their drinking water for 19 days. Kidneys from each group (control, l-NAME-, and l-NAME + losartan-treated rats) were perfusion-fixed in situ, infused with a silicon-based polymer containing lead chromate, and scanned by micro-CT. The microvasculature in the reconstructed three-dimensional renal images was studied using computerized analytic techniques. Kidneys of l-NAME-treated rats had significantly fewer normal glomeruli (28,824 ± 838) than those of control rats (36,266 ± 3,572). Losartan normalized the number to control values (34,094 ± 1,536). The amount of vasculature in the cortex, outer medulla, and inner medulla of l-NAME-treated rats was about two-thirds that of control rats; losartan normalized the values to control levels. These data indicate that chronic treatment with the NO synthase inhibitor l-NAME produces a generalized rarefaction of renal capillaries. Because simultaneous AT1 receptor blockade abolished those changes, the data suggest that the reduction in vasculature is mediated by ANG II through AT1 receptors.Keywords
This publication has 31 references indexed in Scilit:
- Renal cortical remodelling by NO‐synthesis blockers in rats is prevented by angiotensin‐converting enzyme inhibitor and calcium channel blockerJournal of Cellular and Molecular Medicine, 2001
- Losartan-sensitive renal damage caused by chronic NOS inhibition does not involve increased renal angiotensin II concentrationsKidney International, 1999
- Evolution of Chronic Nitric Oxide Inhibition HypertensionHypertension, 1998
- Nitric Oxide in Renal Cortex and MedullaHypertension, 1997
- Changes in nitric oxide precursor, L-arginine, and metabolites, nitrate and nitrite, with agingLife Sciences, 1994
- Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition.Hypertension, 1993
- Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension.Hypertension, 1992
- Role of nitric oxide in renal papillary blood flow and sodium excretion.Hypertension, 1992
- Estimation of Tissue Volume from Serial Tomographic Sections: A Statistical Random Marking MethodInvestigative Radiology, 1988
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976